Key Perspectives in Diagnosing and Managing Restless Legs Syndrome - Patient Follow Up

Neurology
Curriculum:
Key Perspectives in Diagnosing and Managing Restless Legs Syndrome
Credits:
0.5 AANP Contact Hours 0.5 AAPA Category 1 Credit(s) 0.5 AMA PRA Category 1 Credit(s)™
Launch Date:
May 01, 2014
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Neurologists, Psychiatrists, Sleep Clinicians, Nurse Practitioners, Physician Assistants, Primary Care Physicians

Relevant Terms:

Sleep Disorders, Sleep Medicine

Philip M. Becker, MD

Philip M. Becker, MD
President
Sleep Medicine Associates of Texas, PA
Dallas, TX

Philip M. Becker, MD, is President of Sleep Medicine Associates of Texas, PA in Dallas and Clinical Professor in the Department of Psychiatry at the University of Texas Southwestern Medical Center at Dallas. Dr. Becker received his medical degree from the Medical College of Wisconsin in Milwaukee, followed by a residency in psychiatry at the University of Minnesota Hospitals in Minneapolis and additional training in sleep disorders at Minnesota Regional Sleep Disorders Center in Minneapolis. He is certified by the American Board of Psychiatry and Neurology with added qualification in Sleep Medicine, and by the American Board of Sleep Medicine.
 
Author or co-author of numerous articles, book chapters, abstracts, and essays, Dr. Becker is a reviewer for SLEEPAmerican Family PhysicianBiological Psychiatry, and Sleep Medicine, for which he is also an editorial board member. He has given more than 400 lectures to practicing physicians on topics including sleep disorders, restless legs syndrome, and sleep apnea. Dr. Becker is a member of the Sleep Research Society, the American College of Physician Executives, and the American Medical Association.  He is a Fellow of the American Academy of Sleep Medicine and a Distinguished Fellow of the American Psychiatric Association. He has served as Treasurer of the American Board of Sleep Medicine and President of the Southern Sleep Society.

David B. Rye, MD, PhD

David B. Rye, MD, PhD
Professor of Neurology
Emory University School of Medicine
Atlanta, GA


Dr. Rye graduated from the Medical Scientist Training Program of the University of Chicago with a doctor of philosophy in neurobiology and a medical degree. After finishing a medical internship at Michael Reese Hospital in Chicago, he completed a neurology residency as Chief at the University of Chicago Hospitals in 1992. Thereafter, he moved to Emory University where he helped establish and build a program in sleep medicine, attaining the position of tenured full professor in 2010. Dr. Rye is a clinician scientist and systems neurobiologist with an interest in the pathophysiological basis and treatment of restless legs syndrome/periodic leg movements of sleep as well as the primary hypersomnias. He is a recipient of the American Academy of Neurology Sleep Science Award and Sleep Research Society Outstanding Scientific Achievement Award for his role in discovery of the first genetic determinants of restless legs, and the Narcolepsy Network Researcher of the Year in recognition of his group's recent advances in unraveling the origins of, and novel treatment paradigms for, the primary hypersomnias.

John W. Winkelman, MD, PhD

John W. Winkelman, MD, PhD
Associate Professor of Psychiatry
Harvard Medical School
Associate Physician
Massachusetts General Hospital
Boston, MA


Dr. Winkelman is Associate Professor in Psychiatry at Harvard Medical School and Associate Physician in the Division of Sleep Medicine, Brigham and Women's Hospital in Boston, Massachusetts. He received his medical degree from Harvard Medical School and his doctorate in psychobiology from Harvard University and completed both a residency in psychiatry and a fellowship in Sleep Medicine at Massachusetts General Hospital. He was Medical Director for the McLean Hospital Sleep Program (1991-1996) and subsequently Medical Director at the sleep laboratory at Brigham and Women's Hospital (1996-2013). Currently, he is Chief of the Sleep Disorders Clinical Research Program in the Department of Psychiatry at Massachusetts General Hospital. 
 
Dr. Winkelman's research has primarily focused in two areas: 1) epidemiology, physiology, cardiovascular consequences and treatment of restless legs syndrome, and 2) neurobiology and treatment of insomnia. He has lectured in and directed post-graduate medical education courses in sleep disorders nationally and internationally. Dr. Winkelman is Chair of the American Academy of Neurology practice parameter committee for the treatment of restless legs syndrome, on the executive committee of the International RLS Study Group, is an Associate Editor of Sleep and serves on the editorial boards of Sleep Medicine and CNS Drugs. He has published more than 100 articles, reviews and book chapters and is also the editor of the textbook Foundations of Psychiatric Sleep Medicine, Cambridge University Press (2011).
1. Describe clinical features of RLS including common comorbid conditions that impact sleep
2. Discuss the potential differential diagnosis of RLS and how to make diagnostic distinctions
3. Discuss safety and efficacy data for current treatment approaches for RLS
4. Effectively and appropriately manage patients with RLS, including consideration of medications and other factors that may improve or worsen their symptoms

Statement of Accreditation - Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Atlanta School of Sleep Medicine and Technology and RMEI, LLC. The Atlanta School of Sleep Medicine and Technology is accredited by the ACCME to provide continuing medical education for physicians.

Designation of Credit
The Atlanta School of Sleep Medicine and Technology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Statement of Accreditation - Nurse Practitioners

This program is approved for 0.5 contact hour of continuing education by the American Association of Nurse Practitioners. 
Program ID: 1404195

This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

 
Statement of Accreditation - Physician Assistants

This program has been reviewed and is approved for a maximum of 0.5 hour of AAPA Category I CME credit by the Physician Assistant Review Panel.
Program ID: 001594

This program was planned in accordance with AAPA's CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.

General Disclosures:
It is the policy of the Atlanta School of Sleep Medicine and Technology to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty participating in programs sponsored or jointly sponsored by the Atlanta School of Sleep Medicine and Technology are expected to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation(s). All slides and case-based material in this presentation have been subject to peer review to ensure independence of medical content. The content reviewer, Heidi Riney, MD, Diplomate, ABPN – Sleep Medicine, has no relevant financial relationships to disclose.
 
DISCLOSURE OF CONFLICTS OF INTEREST
The planners, managers and faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity
:
 
Faculty Disclosures
  • Philip M. Becker, MD, has affiliations with Xenoport (Consulting); UCB Pharma and Xenoport (Speaker's Bureau).
  • David B. Rye, MD, PhD, has affiliations with Jazz Pharma, UCB Pharma and Xenoport (Consulting).
  • John W. Winkelman, MD, PhD, has affiliations with UCB Pharma (Consulting); UCB Pharma (Research).
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

RMEI, LLC
  • Jacqui Brooks, MBBCh, MRCPsych, has no affiliations with commercial interests relative to the content to disclose.
  • Nora Hartley has no affiliations with commercial interests relative to the content to disclose.
  • Marie Laney has no affiliations with commercial interests relative to the content to disclose.
Atlanta School of Sleep Medicine and Technology​
  • Russell Rosenberg, PhD, has no affiliations with commercial interests relative to the content to disclose.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 
 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
 
Estimated time to complete: 0.5 hour
Medium: Internet

FEE INFORMATION
There is no fee for this educational activity.

COMMERCIAL SUPPORT
This activity is supported by an independent educational grant from UCB Pharmaceuticals.

HOW TO RECEIVE CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners and physician assistants are entitled to receive up to 0.5 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page.
  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the post-test and activity evaluation.
  • Physicians, nurse practitioners and physician assistants who successfully complete the post-test and evaluation will receive CME/CE credit. You must score 65% or higher on the post-test to receive credit for this activity.
  • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
COURSE VIEWING REQUIREMENTS
Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 5.0+ for Mac OSX 10.5 and above

For video playback, install the latest version of Flash or Quicktime.
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above